Literature DB >> 23920368

Development of refractive error in individual children with regressed retinopathy of prematurity.

Jingyun Wang1, Xiaowei Ren, Li Shen, Susan E Yanni, Joel N Leffler, Eileen E Birch.   

Abstract

PURPOSE: We investigated longitudinally the refraction development in children with regressed retinopathy of prematurity (ROP), including those with and those without a history of peripheral retinal laser photocoagulation.
METHODS: Longitudinal (0-7 years) cycloplegic refraction data were collected prospectively for two groups of preterm children: severe ROP group included those with regressed ROP following bilateral panretinal laser photocoagulation (n = 37; median gestational age [GA] = 25.2; range, 22.7-27.9 weeks) and mild/no ROP group included those with spontaneously regressed ROP or no ROP (n = 27; median GA = 27.1; range, 23.1-32.0 weeks). Analyses were based on spherical equivalent (SEQ), anisometropia, astigmatism, and age (corrected for gestation).
RESULTS: The prevalence, magnitude, and rate of myopic progression all were significantly higher in the severe ROP group than in the mild/no ROP group. Longitudinal SEQ in the severe ROP group were best fit with a bilinear model. Before 1.3 years old, the rate of myopic shift was -4.7 diopters (D)/y; after 1.3 years, the rate slowed to -0.15 D/y. Longitudinal SEQ in the mild/no ROP group was best fit with a linear model, with a rate of -0.004 D/y. Anisometropia in the severe ROP group increased approximately three times faster than in the mild/no ROP group. In the severe ROP group, with-the-rule astigmatism increased significantly with age.
CONCLUSIONS: The severe ROP group progressed rapidly toward myopia, particularly during the first 1.3 years; anisometropia and astigmatism also increased with age. The mild/no ROP group showed little change in refraction. Infants treated with laser photocoagulation for severe ROP should be monitored with periodic cycloplegic refractions and provided with early optical correction.

Entities:  

Keywords:  laser photocoagulation; myopia; refractive error development; retinopathy of prematurity

Mesh:

Year:  2013        PMID: 23920368      PMCID: PMC3771557          DOI: 10.1167/iovs.13-11765

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  41 in total

1.  Diode laser photocoagulation for retinopathy of prematurity: a histopathologic study.

Authors:  P Park; R C Eagle; W S Tasman
Journal:  Ophthalmic Surg Lasers       Date:  2001 Jan-Feb

2.  A longitudinal study of the biometric and refractive changes in full-term infants during the first year of life.

Authors:  F C Pennie; I C Wood; C Olsen; S White; W N Charman
Journal:  Vision Res       Date:  2001-09       Impact factor: 1.886

3.  Long term refractive outcome in eyes of preterm infants with and without retinopathy of prematurity: comparison of keratometric value, axial length, anterior chamber depth, and lens thickness.

Authors:  M Y Choi; I K Park; Y S Yu
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

4.  Change of refractive state and eye size in children of birth weight less than 1701 g.

Authors:  A R O'Connor; T J Stephenson; A Johnson; M J Tobin; S Ratib; A R Fielder
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

5.  Peripheral vision can influence eye growth and refractive development in infant monkeys.

Authors:  Earl L Smith; Chea-Su Kee; Ramkumar Ramamirtham; Ying Qiao-Grider; Li-Fang Hung
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-11       Impact factor: 4.799

6.  Therapeutic outcomes of cryotherapy versus transpupillary diode laser photocoagulation for threshold retinopathy of prematurity.

Authors:  E A Paysse; J L Lindsey; D K Coats; C F Contant; P G Steinkuller
Journal:  J AAPOS       Date:  1999-08       Impact factor: 1.220

Review 7.  Long term functional and structural outcomes of laser therapy for retinopathy of prematurity.

Authors:  E McLoone; M O'Keefe; S McLoone; B Lanigan
Journal:  Br J Ophthalmol       Date:  2006-06       Impact factor: 4.638

8.  The influence of retinopathy of prematurity on ocular growth.

Authors:  D Kent; F Pennie; D Laws; S White; D Clark
Journal:  Eye (Lond)       Date:  2000-02       Impact factor: 3.775

9.  Cycloplegic refractions in healthy children aged 1 through 48 months.

Authors:  D L Mayer; R M Hansen; B D Moore; S Kim; A B Fulton
Journal:  Arch Ophthalmol       Date:  2001-11

10.  Long-term effect of antiangiogenic therapy for retinopathy of prematurity up to 5 years of follow-up.

Authors:  María A Martínez-Castellanos; Shulamit Schwartz; Myriam L Hernández-Rojas; Veronica A Kon-Jara; Gerardo García-Aguirre; José L Guerrero-Naranjo; R V Paul Chan; Hugo Quiroz-Mercado
Journal:  Retina       Date:  2013-02       Impact factor: 4.256

View more
  21 in total

1.  One-year clinical outcome after laser treatment for retinopathy of prematurity at a tertiary center in Turkey.

Authors:  Murat Gunay; Gokhan Celik; Fahri Ovali; Huseyin Yetik; Alev Aktas; Betul Onal Gunay
Journal:  Int Ophthalmol       Date:  2014-11-09       Impact factor: 2.031

2.  Long-term evaluation of refractive changes in eyes of preterm children: a 6-year follow-up study.

Authors:  Mahmut Kaya; Ayse Tulin Berk; Aylin Yaman
Journal:  Int Ophthalmol       Date:  2017-07-01       Impact factor: 2.031

3.  Visual outcome and refractive status in first 3 years of age in preterm infants suffered from laser-treated Type 1 retinopathy of prematurity (ROP): a 6-year retrospective review in a tertiary centre in Hong Kong.

Authors:  Julie Y C Lok; Wilson W K Yip; Abbie S W Luk; Joyce K Y Chin; Henry H W Lau; Alvin L Young
Journal:  Int Ophthalmol       Date:  2017-01-04       Impact factor: 2.031

4.  Ultra-low dose of intravitreal bevacizumab in retinopathy of prematurity.

Authors:  A Şahin; Z Gürsel-Özkurt; M Şahin; F M Türkcü; A Yıldırım; H Yüksel
Journal:  Ir J Med Sci       Date:  2017-10-07       Impact factor: 1.568

5.  Eye growth in term- and preterm-born eyes modeled from magnetic resonance images.

Authors:  Robert J Munro; Anne B Fulton; Toco Y P Chui; Anne Moskowitz; Ramkumar Ramamirtham; Ronald M Hansen; Sanjay P Prabhu; James D Akula
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

6.  Refractive and Visual Outcome after Laser-Treated Retinopathy of Prematurity in Western Romania.

Authors:  Florina Stoica; Corina Ladariu; Marie-Jeanne Koos; Alina Stanciu; Gabriela Olariu; Nicoleta Andreescu; Maria Puiu
Journal:  Maedica (Buchar)       Date:  2016-06

7.  Refractive status, biometric components, and functional outcomes of patients with threshold retinopathy of prematurity: systemic review and a 17-year longitudinal study.

Authors:  Yu-Bai Chou; An-Guor Wang; Hsin-Yu Yang; Kuan-Jung Chen; Chang-Sue Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-06-22       Impact factor: 3.117

8.  Longitudinal Change of Refractive Error in Retinopathy of Prematurity Treated With Intravitreal Bevacizumab or Laser Photocoagulation.

Authors:  Emily Wiecek; James D Akula; Deborah K Vanderveen; Iason S Mantagos; Carolyn Wu; Amber-Lee Curran; Hanna De Bruyn; Bridget Peterson; Anne B Fulton
Journal:  Am J Ophthalmol       Date:  2022-03-31       Impact factor: 5.488

9.  The rat with oxygen-induced retinopathy is myopic with low retinal dopamine.

Authors:  Nan Zhang; Tara L Favazza; Anna Maria Baglieri; Ilan Y Benador; Emily R Noonan; Anne B Fulton; Ronald M Hansen; P Michael Iuvone; James D Akula
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-19       Impact factor: 4.799

10.  Ten-year outcomes after initial management with laser photocoagulation versus intravitreal bevacizumab injection in a pair of identical twins with aggressive posterior retinopathy of prematurity.

Authors:  Seung Hee Jeon; Young-Jung Roh
Journal:  Am J Ophthalmol Case Rep       Date:  2021-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.